Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Cogn Behav Ther. 2022 Feb 23;51(4):273–294. doi: 10.1080/16506073.2022.2037017

Table 3.

BE-FIT Outcomes and effect sizes

BEFIT (N=12) Control (N=7) Between
Baseline
M (SD)
End of Treatment
M (SD)
t p Hedge’s g CI Baseline
M (SD)
End of Treatment
M (SD)
t p Hedge’s g CI Partial eta2
ESQ-Total 44.2 (11.5) 25.6 (15.6) 3.44 .005 0.960 0.271, 1.621 36.7 (10.5) 30.1 (14.7) 1.25 .257 0.443 −0.308, 1.162 0.113
ESQ-Pain/weakness 16.4 (8.1) 8.3 (6.6) 2.94 .013 0.820 0.164, 1.449 11.7 (7.2) 10.1 (7.0) 0.52 .619 0.185 −0.523, 0.879 0.121
ESQ-Cardiopulmonary 27.8 (5.1) 17.3 (9.3) 3.25 .008 0.907 0.231, 1.555 25.0 (5.0) 20.0 (8.0) 1.85 .114 0.653 −0.149, 1.414 0.072
Avg Steps/Day 5758.8 (2940.6) 7761.5 (3684.4) −4.35 .001 −1.211 −1.937, −0.456 5979.7 (4795.7) 5936.2 (3369.5) 0.05 .963 0.017 −0.677, 0.71 0.229
Avg MVPA min/day 20.5 (16.9) 48.9 (35.2) −3.32 .007 −0.926 −1.578, −0.245 30.2 (32.1) 27.7 (23.0) 0.46 .661 0.163 −0.543, 0.856 0.279

Note: M (SD) = mean (standard deviation); CI = confidence interval; ESQ = Exercise Sensitivity Questionnaire; MVPA = Moderate-vigorous physical activity.